Co-Diagnostics, Inc.
Price Action
Technical Summary
CONSOLIDATINGCo-Diagnostics, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is leading (RS Rating: 99), indicating clear outperformance against the broad market. Earnings growth of 42% provides fundamental context to the price action. Investors should exercise caution due to high volatility (238% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $4.28 | -30.41% | BELOW |
| 50 SMA | $3.43 | -13.13% | BELOW |
| 100 SMA | $2.81 | +6.18% | ABOVE |
| 150 SMA | $17.81 | -83.27% | BELOW |
| 200 SMA | $16.41 | -81.84% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is CODX in an uptrend right now?
CODX has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is CODX overbought or oversold?
CODX's RSI (14) is 43. The stock is in neutral territory, neither overbought nor oversold.
Is CODX outperforming the market?
CODX has a Relative Strength (RS) Rating of 99 out of 99. Yes, CODX is a market leader, outperforming 99% of all stocks over the past 12 months.
Where is CODX in its 52-week range?
CODX is trading at $2.98, which is 22% of its 52-week high ($13.53) and 21% above its 52-week low ($0.18).
How volatile is CODX?
CODX has a Beta of 1.51 and 52-week volatility of 238%. It's more volatile than the S&P 500 - expect bigger swings.